Recall Z-1636-2021— BIOPSYBELL S.R.L.
Class II · Terminated
Class II FDA medical device recall by BIOPSYBELL S.R.L., initiated 2021-03-22, terminated 2026-02-17. FDA's recall record names no specific 510(k) clearance for this event. Product: EASYNJECT, Device for cement infusion in the vertebroplasty procedure, REF KVTGUN-DS. Reason: Products labeled as sterile were distributed, but may not have been sterilized..
- Recalling firm
- BIOPSYBELL S.R.L.
- Classification
- Class II
- Status
- Terminated
- Initiated
- 2021-03-22
- Terminated
- 2026-02-17
- Firm location
- Mirandola, N/A, Italy
Product description
EASYNJECT, Device for cement infusion in the vertebroplasty procedure, REF KVTGUN-DS
Reason for recall
Products labeled as sterile were distributed, but may not have been sterilized.
Data sourced from openFDA. This site is unofficial and independent of the FDA.